Dr. Max Seaton, M.D.
Surgical Oncology
66% Complete
Profile completeness
ZIP Healthcare Access Score
Healthcare Paradise
ZIP 99216 • A+
14+
Years in Practice
Healthcare Access Where Dr. Max Seaton Practices
ZIP code 99216 • Spokane, Washington
Residents of ZIP 99216 have exceptional access to healthcare across all dimensions.
View full Healthcare Access Score report for ZIP 99216Conditions Dr. Max Seaton Can Help With
Based on specialty, these are the relevant healthcare access scores for the practice area
Practice Locations
1 location
About Dr. Max Seaton
Max Seaton, M.D. is a healthcare provider practicing in Spokane Valley, WA.
Specialty Definition
A surgical oncologist is a well-qualified surgeon who has obtained additional training and experience in the multidisciplinary approach to the prevention, diagnosis, treatment, and rehabilitation of cancer patients, and devotes a major portion of his or her professional practice to these activities and cancer research.
14
Years Experience
1
Location
1
States Licensed
Credentials & Board Certifications
Primary Specialty
Surgical OncologyCredentials verified via NPI Registry (NPPES)
Education & Training
Medical School
Other
Class of 2012
Licenses & Practice States
Licensed in 1 state
| State | License | Classification | Primary |
|---|---|---|---|
| Washington | MD61171490 | Surgery |
Public Data Summary for Dr. Max Seaton
With 14 years of practice, Dr. Max Seaton is an established surgical oncology provider, M.D., after earning their medical degree at Other in 2012. Dr. currently practices at American Oncology Partners Pa in Spokane Valley, Washington. Their National Provider Identifier (NPI) is 1184980260, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
Dr. Max Seaton's practice is located in ZIP 99216 (Spokane Valley, Washington), which has an overall CartoChrome Healthcare Access Score of 98/100 (Healthcare Paradise). Patients in this area have comparatively strong access to primary care, specialists, and hospital services.
CMS Medicare data shows Dr. Max Seaton as a lower-volume surgical oncology provider, treating approximately 106 Medicare beneficiaries and delivering 746 services in the most recent reporting year. That panel size indicates a smaller, more selective practice pattern.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Max Seaton received $581 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$581
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Max Seaton
--
0 reviews
Surgical Oncology Providers Nearby
Same primary specialty near ZIP 99216
FAQ
Frequently asked questions about Dr. Max Seaton
What does Dr. Max Seaton specialize in?
Dr. Max Seaton specializes in Surgical Oncology.
Where does Dr. Max Seaton practice?
Dr. Max Seaton practices at American Oncology Partners Pa in Spokane Valley, Washington.
Does Dr. Max Seaton accept Medicare?
Based on CMS records, Dr. Max Seaton has not filed a Medicare opt-out affidavit, which means they typically accept Medicare-covered patients. CMS billing data shows 106 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Max Seaton's NPI number?
Dr. Max Seaton's National Provider Identifier (NPI) is 1184980260. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Max Seaton been practicing?
Dr. Max Seaton has approximately 14 years of practice experience, having graduated from Other in 2012.